The ES 600 sample^selective multibatch analyser was subjected to a multicentre evaluation in six laboratories in accordance with ECCLS guide-lines. During the 3-month trial, five Enzymun-Test® diagnostics (T 4 , TBG, Digoxin, CEA and TSH)') were measured at 25 °C.
Introduction
The proportion of determinations in the clinical chemistry laboratory based on immunochemical methods is continually increasing. Because of the problems associated with radioimmunoassays (special equipment, disposal of waste), the various enzyme-immunoassays are becoming more important. In addition to the rising number of determinations, however, increasingly strict requirements are being placed on the reproducibility of the results in order to meet the increasing demands, for example in following the course of tumours via long-term monitoring with appropriate tumour markers. This makes mechanisation of such procedures necessary.
The first step towards a partially mechanized instrument was made with the ES 22 (1) . The ES 600 now available is a fully mechanized instrument which meets all requirements.
The ES 600 system, the instrument together with the corresponding enzyme-immunoassays, was subjected to a multicentre trial in six laboratories in accordance with the recommendations of the ECCLS (2) . The goal of the study was the verification of the function of the instrument by comparison with another mechanized procedure for the performance of EnzymunTest® methods, which has already been investigated against manual techniques.
Description of the ES 600
Enzymun-Test® System ES 600 (ES 600) is a fully mechanized instrument for carrying out, measuring, evaluating and documenting heterogeneous enzyme-immunoassays, in particular those methods based on coated tube technology (ELJSA). In addition, turbidometric assays can also be carried out on the instrument.
The ES 600 is a sample-selective multibatch analyser with a modular construction. Within a single run, the instrument carries out up to 15 tests (freely selectable by the user) on up to 150 samples, using up to 600 coated tubes without involvement of the user.
Details of the instrument specifications based on the IFCC guidelines (3, 4) are given in table 1.
Tab. 1. Specification of the ES 600 Enzyniun-Test® System
according to the guide-lines of the IFCC (3, 4).
Type
Sample-selective multibatch analyser.
Testing
Enzymun-immunoassay, turbidimetric improcedure munoassays.
Evaluation via non-linear calibration curves. A choice of 4 curve functions is available for making the evaluation.
Throughput Work cycle 11s. Up to 650 working steps per hour (via parallel procedures).
The throughput is dependent upon the nun> ber of samples, incubation times, methods used and length of series.
Samples
Sample transport: sample rotor with 150 positions for samples and standards together with ail additional 10 positions for control sera.
Sample vessels, graduated plastic vessels, tilizable volume 2.0 ml. Dispensing: dispensing syringe driven by stepping motor.
Sample volumes: 5-200 μΐ; selectable in 1 μΐ increments by the user.
Reagents
Transport: reagent rotor with 15 positions; up to 4 reagents per method can be used. 
Methods

Participants and reagents
Six clinical chemistry laboratories took part in the multicentre evaluation of the ES 600. Five enzyme-immunoassays were employed in the investigations. The test-specific properties of Enzymun-Test® T 4 (5, 11), TBG (6, 7), Digoxin (8), TSH (9) and CEA (10) have already been determined in separate evaluations. Data on the instrument settings for measurements carried out at 25 °C are given in table 2.
Investigations
The testing of the instrument was based on the ECCLS recommendations for the evaluation of clinico-chemical analysers (2) .
Within-series precision
In order to determine the within-series precision, three control sera containing the corresponding analytes in differing concentrations were used. All six laboratories worked with the same control materials. In addition, each laboratory prepared three human serum pools having differing analyte concentrations; these were also used for the determination of within-series precision. Each measurement of precision with 20 duplicate determinations was carried out twice.
Between-series precision
In order to determine the between-series precision, duplicate determinations were carried out twice daily on three control sera for 10 days. The same procedure was carried out with two human serum pools prepared in the respective laboratories. Lvaluation was always made using the second value obtained.
Trend in measurements
In at least 5 series, the complete group of standards was again determined at the end of the series, and the absorbances compared with those obtained at the beginning of the series; in addition, a standard curve was calculated from the results each time.
Method comparison
In order to rule out effects due to reagent differences, about 80 human sera were determined in parallel with the same reagents on the ES 600 and the ES 22 (1) using duplicate determinations. The same sera were also determined using the routine method of the respective laboratory.
Linearity
Each laboratory prepared a ΙΟ-step dilution series from a human serum with a high analyte content and a human serum with a low analyte content. This procedure was carried out for all five analytes. The dilutions were measured in series using two duplicate determinations each time.
Carry-over
The carry-over experiments were carried out in such a way that three duplicate determinations of a human serum with the highest possible analyte concentration were followed by three duplicate determinations of a serum having a low concentration. This sequence was measured ten times successively within a series. Mean coefficients of variation of 3% were found over the entire measuring range for the competitive methods for thyroxine (T 4 ) ( fig. 1 ), thyroxine binding globulin (TBG) ( fig. 2) and digoxin ( fig. 3 ). Also in the lower and higher measuring ranges, no values were found above 8.5% for thyroxine, 6.4% for thyroxine binding globulin and 8.0% for digoxin.
For the determinations based on the sandwich principle, i.e. carcinoembryonic antigen (CEA) ( fig. 4 ) and thyrotropin (TSH) ( fig. 5 ), the coefficient of variation showed a greater dependence on the concentration of the sample measured; this was due to the large measuring range and the position of the calibration curve. As this effect only becomes manifest in the lower range, the mean coefficients of variation are generally about 2% for carcinoembryonic antigen and 5% for thyrotropin. Coefficients of variation of 20% were only found in samples containing the analyte in the lower concentration range in the vicinity of the method detection limit in individual series.
Between-series precision
The results are summarized in table 4 and presented graphically in figures 6-10 for the human serum pools measured.
Here, too, the competitive methods show only a slight dependence upon concentration. For thyroxine (fig .  6 ) the mean CV is 7%, with the values from all of the laboratories involved being below 10%.
Thyroxine binding globulin measurements in human serum pools ( fig. 7 ) yielded a mean CV of 7% although three values were distinctly higher (up to 15%). For digoxin ( fig. 8 ), the mean CV was 6% whereas in human serum pools values of up to 17% were obtained at the lower detection limit.
For the thyrotropin and carcinoembryonic antigen protein determination used within the framework of the multicentre study, a greater concentration^-pendence of the between-series imprecision was measured. For carcinoembryonic antigen ( fig. 9 ), the mean value is 7% (with the very good precision in the higher measuring range contributing to this), whereas in the lowest measuring range the CV is up to 16%. One serum pool was considerably above the measuring range of the method (50 g/l). The concentration- In all laboratories, the individual values show a normal distribution and only differ slightly from the common mean.
Measurement trend
Because of the calibration necessary in each ran, the procedure recommended by the ECCLS was modified somewhat so that the standards used for calibration were again employed as samples at the end of lengthy measurement series. As an example figure 16 shows the calibration curves for the absorbances of the standards at the beginning and end of the series for Enzymun-Test® T 4 .
No trend in the measurements can be seen for any of the methods. The absorbances of the standards at the beginning and end of the series lie within the measurement tolerances and show no systematic differences. The ECCLS guidelines for the evaluation of analysers in clinical chemistry recommend that the conditions for the comparison should be, as far as possible, the same, i. e. using the same reagents (including standards). For this reason comparisons with the results obtained using the procedure on the ES 22 were used to assess the instruments. As a generality it should be noted that the precision of determinations using the ES 22 is not as good as that obtained using the ES 600. The results for the individual tests are given in tables 5 -9 for all laboratories and also graphically (figs 17-21).
Statistical evaluation was made according to the nonparametric procedure given by Bablok & Passing (12, 13) .
The following individual results were obtained: Enzymum-Test® Digoxin ( fig. 19 ) In this test also, the results on the ES 22 agree very well with those obtained on the ES 600.
Enzymum-Test® CEA ( fig. 20 ) When assessing the results in table 8, the small concentration range used in some cases (laboratories 1, 2 and 6) must be taken into account. On the whole, however, no systematic deviation can be observed here either. (fig. 21 ) Here, too, the result is influenced by the use of sample materials in a very narrow measuring range (laboratories 2 and 6). The agreement is, however, also very good.
Enzymum-Test® TSH
Linearity/measuring range
This investigation was carried out by blending a hum an serum containing a high analyte concentration with a human serum containing as low an analyte concentration as possible.
The results are given in figures 22-26. No deviation within the measuring ranges defined by the standards were found for any of the methods. As a result of the measuring conditions (3 mm path length of the cuvette) and the excellent linearity of the photometer, it would have been possible to make measurements over a greater measuring range; however, interpolation beyond "the range defined by the standards cannot be carried out with non-linear calibrator! curves. 1. technical changes to the instrument, and 2. alterations to the user software.
The technical changes to the instrument mainly concern modifications to increase the reliability of instrument function (particularly concerning tube transport and the wash station). These changes were carried out immediately. The corrections to the user software took somewhat more time, but were not decisive for the reliability of instrument function.
In addition to the less serious defects, the modifications are mainly related to the installation of a bidirectional interface, which for differently organized laboratories greatly simplifies and accelerates the necessary input for the RUN definition. In addition to the normal input via keyboard and display screen, it is also possible to enter requests for analyses from patient samples directly via the laboratory electronic data processing or with the aid of a barcode reader, thereby substantially shortening the preparation time. This additionally increases the rationalization effect by a further saving in laboratory capacity.
The ES 600 instrument provides a further possibility for lowering analysis costs, namely by carrying out determinations as single analyses and employing recalibration with only one standard in association with stored calibration curves. From the present evaluation one can conclude that this possibility will be exploited.
Investigator's Summary
The results show that with the help of the ES 600, analytical quality in terms of precision and reliability can be achieved in the field of immunochemistry which is comparable to the state of the art in clinical chemistry. It is hence possible to carry out immunoassays with Enzyinun^Test® diagnostics as single determinations on the ES 600 instrument without loss of accuracy and precision.
The multicentre study was carried out with instruments from the first production series. As a result of this early period in the development of the instrument, it became obvious during the evaluation that modifications were necessary, although no basic changes to the instrument concept were required for the production series. The alterations can be summarized into two areas:
Follow-Up Measurement Programme
After instrument modifications, a follow-up measuring programme was carried out in four laboratories in order to check the improvement in instrument reliability. For this purpose, measurements aimed at determining the within-series and between-series precisions were generally carried out using control sera (Precinorm® IM and Precipath® IM) together with human serum pools.
The results are summarized in tables 11 and 12. Particularly for the between-series precision (tab. 12), lower coefficients of variation were found. These values are as a rule well below 10%; for the medium concentration range the coefficients of variation were generally found to be below 5%. In addition the reliability of the instrument was clearly improved. 
